Health score, price, valuation, risk signals, and key metrics at a glance.
Strongest: Profitability (20/25); weakest: Balance Sheet & Red Flags (10/25).
Data-driven signals worth keeping an eye on across the last 8 quarters
FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.
D/E ratio is 3.2 — heavily leveraged and vulnerable to rising rates or cash flow dips.
as of December 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Revenue has softened, declining in 5 quarters. Watch for further erosion.